A further common genetic alteration is ATR amplification that is found in about 10.1% of lung squamous-cell carcinoma, ~6.6% of esophageal cancer, ~5.7% of head and neck carcinomas and a minority of other cancer cases (Supplementary Figure 2) (23). This evidence concerns the gene ATR and squamous cell lung carcinoma.